canertinib has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, X; Fu, W; Lu, K; Lv, M; Wang, L | 1 |
1 other study(ies) available for canertinib and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
Topics: Animals; Antioxidants; Apoptosis; Astragalus Plant; Diabetic Cardiomyopathies; Morpholines; Myocytes, Cardiac; Neuregulin-1; Oncogene Proteins v-erbB; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Polysaccharides; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |